Meeting News

Carillon device for mitral valve repair may improve long-term survival

February 27, 2020
Patients with congestive HF and grade 2 to 4 functional mitral regurgitation despite medical therapy who underwent transcatheter mitral valve repair…

Meeting News

Oral anticoagulation after low-risk TAVR safely reduces leaflet thrombosis

February 26, 2020
Low-risk patients who underwent transcatheter aortic valve replacement and took oral anticoagulation for 30 days had lower incidence of leaflet…

FDA News

Long-term ECMO system receives FDA clearance

February 25, 2020
The FDA recently cleared the Novalung extracorporeal membrane oxygenation system — the first to be cleared for more than 6 hours of use as…

In the Journals

AI platform with wearable sensor patch may predict HF rehospitalizations

February 25, 2020
A wearable sensor predicted HF rehospitalizations with similar predictive accuracy to implantable devices, according to data from the LINK-HF study…

In the JournalsPerspective

Making tafamidis cost-effective for TTR amyloid cardiomyopathy may require 93% price reduction

February 19, 2020
Although tafamidis can provide substantial clinical benefit for patients with transthyretin amyloid cardiomyopathy, the drug exceeds…

In the Journals

In CV trials, representation of women varies by funding source, disease type, trial size

February 17, 2020
Although overall representation remained low, the extent of women’s inclusion in CV trials may depend on trial characteristics such as…

Trial Scorecards

SIRONA

Cardiology Today, February 2020
First-in-human study of sensor (Cordella, Endotronix) to measure pulmonary artery pressure in patients with HF.

Cover StoryPerspective

New treatments, increased awareness shine spotlight on cardiac amyloidosis

Cardiology Today, February 2020
Amyloidosis, a disease in which misfolded proteins form amyloid fibrils that deposit in tissues and organs including the heart, is a vexing condition…

In the Journals

Monitoring physical activity via implantable device may predict HF hospitalization, death

February 16, 2020
Remote monitoring using implantable devices to measure daily physical activity proved efficacious in identifying patients with HF who were at risk…

Feature

Q&A: Cardiac Rehabilitation Week underscores barriers to care, need for adherence

February 14, 2020
The American Association of Cardiovascular and Pulmonary Rehabilitation’s annual Cardiac Rehabilitation Week began Sunday with the new theme…

Feature

Q&A: HF Awareness Week spotlights recent advances in treatment, new research

February 13, 2020
Sunday marked the start of national Heart Failure Awareness Week, a campaign with the aim of promoting not only heart health, but awareness of the…

In the JournalsPerspective

Meta-analysis provides new insights on CV risk with rosiglitazone

February 12, 2020
Rosiglitazone was linked to an increased CV risk, particularly for HF events, in trials with available individual patient-level data, according to a…

Cardiac Rehabilitation Week 2020: Top news on barriers to access, participation

February 11, 2020
February 9 to 15, 2020 is Cardiac Rehabilitation Week. In recognition, Healio and Cardiology Today have aggregated a list of the top news articles…

In the Journals

Dapagliflozin reduces AF events in high-risk patients with diabetes

February 11, 2020
High-risk patients with diabetes who were treated with dapagliflozin had a decrease in the incidence of atrial fibrillation and atrial flutter…

In the Journals

Global longitudinal strain predicts CV risk in immune checkpoint inhibitor-related myocarditis

February 8, 2020
Patients with myocarditis related to immune checkpoint inhibitors and either a preserved or reduced ejection fraction had a reduced global…

In the Journals

Epicardial adipose tissue linked to exercise capacity in adults with type 2 diabetes, asymptomatic HF

February 7, 2020
Exercise may be more difficult for those with type 2 diabetes and asymptomatic heart failure than those without these conditions due to more…

Wear Red Day: Raising awareness of disparities, barriers in women’s heart health

February 7, 2020
On Friday, Feb. 7, the Healio team wears red in support of the American Heart Association’s National Wear Red Day campaign to increase…

Meeting News

ACC announces lineup for late-breaking trials

February 5, 2020
The American College of Cardiology has announced the lineup of late-breaking clinical trials scheduled for presentation at the 2020 Scientific…

FDA News

Fully implantable LV assist system designated breakthrough device

February 4, 2020
Abbott announced its fully implantable left ventricular assist system received a breakthrough device designation from the FDA. According to a press…

In the Journals

Low-sodium diet may benefit after HF hospitalization

February 4, 2020
Although adherence to a provided diet was low, patients who were recently hospitalized for HF and adhered to a low-sodium diet had reductions in…